Stereotaxis

Stereotaxis ROA

The Return on Assets (ROA) of Stereotaxis (STXS) as of Nov 4, 2026 is -41.42 %. In the previous year, Return on Assets (ROA) was -51.46 % — a change of -19.51% (higher).

ROA

-41.42 %

YoY

-19.51%

Last updated:

In 2025, Stereotaxis's return on assets (ROA) was -41.42 %, a -19.51% increase from the -51.46 % ROA in the previous year.

The Stereotaxis ROA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

ROA
Date
ROA
Jan 1, 2018
0.63 USD
Jan 1, 2019
-9.71 USD
Jan 1, 2020
-11.64 USD
Jan 1, 2021
-17.57 USD
Jan 1, 2022
-35.85 USD
Jan 1, 2023
-49.42 USD
Jan 1, 2024
-51.46 USD
Jan 1, 2025
-41.42 USD
The Stereotaxis ROA history
YEARROAYoY
-41.42 %-19.51%
-51.46 %+4.12%
-49.42 %+37.85%
-35.85 %+104.05%
-17.57 %+51.01%
-11.64 %+19.81%
-9.71 %-1,640.09%
0.63 %-101.14%
-55.19 %+118.88%
-25.22 %-34.06%
-38.24 %+75.54%
-21.79 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Stereotaxis Stock analysis

What does Stereotaxis do? Stereotaxis Inc, based in St. Louis, Missouri, is a company that specializes in the development and marketing of advanced instruments and services in magnetic resonance imaging (MRI) and electrophysiology (EP). The company was founded in 1990 and its mission is to improve the accuracy, safety, and efficiency of MRI and EP procedures. The business model of Stereotaxis is based on providing a comprehensive range of systems, instruments, and services to support hospitals and clinics in performing MRI and EP procedures. The company focuses on developing innovative technologies and solutions to improve clinical outcomes and provide the best possible treatment for patients. The company has four main divisions: magnetic resonance imaging (MRI), electrophysiology (EP), cardiovascular diagnostics, and cardiology. In the MRI division, the company offers a variety of instruments and systems specifically designed for MRI procedures. This includes magnetic field control systems, imaging systems, sample collection and analysis instruments, and controls to make MRI procedures more efficient. In the electrophysiology division, Stereotaxis offers instruments and systems that facilitate the navigation and control of medical devices during EP procedures. This includes magnetic field controls and other technologies to improve the accuracy of catheter placement and increase safety during procedures. Stereotaxis's cardiovascular diagnostics division offers various services and technologies that facilitate the performance of cardiology procedures. This includes a comprehensive diagnostic platform that allows for the analysis of heart images. The cardiology division of Stereotaxis offers a comprehensive range of solutions to improve the performance of cardiology procedures in cardiology clinics and hospitals. This includes a range of technologies to improve the diagnosis and treatment of heart diseases. In recent years, Stereotaxis has developed a variety of innovative solutions and technologies to improve the performance of MRI and EP procedures. One example is Robotic Magnetic Navigation, a technology developed by the company to improve the accuracy and safety of EP procedures. This technology allows doctors to improve the navigation and control of catheters during procedures, thereby providing patients with increased treatment safety. Another example is Stereotaxis's Odyssey platform, a solution developed to enable real-time connectivity between various medical devices. This allows doctors to access a variety of information during procedures and make the performance of procedures more efficient. Overall, Stereotaxis has an impressive track record in the development and marketing of advanced solutions and technologies in the MRI and EP industry in recent years. With its innovative technology and comprehensive range of instruments and services, the company is well positioned to continue playing a key role in healthcare in the future. Stereotaxis is one of the most popular companies on Eulerpool.

ROA Details

Understanding Stereotaxis's Return on Assets (ROA)

Stereotaxis's Return on Assets (ROA) is a key performance indicator that measures the company's profitability in relation to its total assets. It is calculated by dividing the net income by the total assets. A higher ROA indicates efficient asset utilization to generate profits, reflecting managerial effectiveness and financial health.

Year-to-Year Comparison

Comparing Stereotaxis's ROA year-over-year provides insights into the company’s operational efficiency and asset utilization trends. An increasing ROA demonstrates enhanced asset efficiency and profitability, while a declining ROA can indicate operational or financial challenges.

Impact on Investments

Investors consider Stereotaxis's ROA as a crucial metric to evaluate the company’s profitability and efficiency. A higher ROA signifies that the company is effectively utilizing its assets to generate profits, making it a potentially attractive investment.

Interpreting ROA Fluctuations

Variations in Stereotaxis’s ROA can be attributed to changes in net income, asset purchases, or operational efficiencies. Analyzing these fluctuations assists in assessing the company's financial performance, management efficiency, and strategic financial positioning.

Frequently Asked Questions about Stereotaxis stock

Return on Assets (ROA) of Stereotaxis is -41.42 % in 2025.

Return on Assets (ROA) of Stereotaxis changed from -51.46 % to -41.42 %, representing a -19.51% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Return on Assets (ROA) Stereotaxis since 2006 – with annual values, charts, and detailed analysis.

Return on Assets, also known as ROA, is a financial metric used to measure a company's profitability. It is used to determine how effectively a company uses its assets to generate profits. It is also referred to as the ratio of net income to total assets. ROA is an important indicator of a company's overall financial performance as it measures the company's ability to generate more profit from the assets it employs.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Return on Assets (ROA)'s Stereotaxis with sector peers and the industry average to assess whether it is attractive.

To evaluate Return on Assets (ROA)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Return on Assets (ROA).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — Stereotaxis

All Key Metrics — Stereotaxis